Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker BEAM
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 3, 2026 | BEAM Beam Therapeutics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 4, 2026 | BEAM Beam Therapeutics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 8, 2026 | BEAM Beam Therapeutics Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 7, 2026 | BEAM Beam Therapeutics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 5, 2026 | BEAM Beam Therapeutics Inc. | 1.02 Termination of a Material Definitive Agreement | 8-K | 8-K ↗ |
| Feb 24, 2026 | BEAM Beam Therapeutics Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Feb 24, 2026 | BEAM Beam Therapeutics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 24, 2026 | BEAM Beam Therapeutics Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Feb 12, 2026 | BEAM Beam Therapeutics Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Feb 5, 2026 | BEAM Beam Therapeutics Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jan 12, 2026 | BEAM Beam Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 12, 2026 | BEAM Beam Therapeutics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 11, 2025 | BEAM Beam Therapeutics Inc. | 2.01 Completion of Acquisition or Disposition of Assets | 8-K | 8-K ↗ |
| Nov 4, 2025 | BEAM Beam Therapeutics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 5, 2025 | BEAM Beam Therapeutics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 3, 2025 | BEAM Beam Therapeutics Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Jun 6, 2025 | BEAM Beam Therapeutics Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 6, 2025 | BEAM Beam Therapeutics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 10, 2025 | BEAM Beam Therapeutics Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 10, 2025 | BEAM Beam Therapeutics Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Mar 10, 2025 | BEAM Beam Therapeutics Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 10, 2025 | BEAM Beam Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 25, 2025 | BEAM Beam Therapeutics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 13, 2025 | BEAM Beam Therapeutics Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 13, 2025 | BEAM Beam Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 13, 2025 | BEAM Beam Therapeutics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 9, 2024 | BEAM Beam Therapeutics Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 9, 2024 | BEAM Beam Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 6, 2024 | BEAM Beam Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 6, 2024 | BEAM Beam Therapeutics Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Dec 4, 2024 | BEAM Beam Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 4, 2024 | BEAM Beam Therapeutics Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 5, 2024 | BEAM Beam Therapeutics Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 5, 2024 | BEAM Beam Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 5, 2024 | BEAM Beam Therapeutics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
35 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:45 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances